Table 4 Prevalence of hepatitis markers among the adult residents classified based on locality, gender and ethnic grouping
HBsAg | anti-HBs | anti-HBc | |||||||
|---|---|---|---|---|---|---|---|---|---|
No. positive/no.tested | % | 95%CI | No. positive/no.tested | % | 95%CI | No. positive/no.tested | % | 95%CI | |
21-49 years | 12/370 | 3.2% | 1.8-5.8 | 107/370 | 28.9% | 24.4-33.9 | 75/370 | 20.3% | 16.4-24.8 |
Division | |||||||||
Central | 10/149 | 6.7% | 3.3-12.0 | 50/149 | 33.6% | 26.0-41.7 | 35/149 | 23.5% | 16.9-31.1 |
Western | 1/148 | 0.7% | 0.0-3.7 | 17/148 | 11.5% | 6.8-17.8% | 19/148 | 12.8% | 7.9-19.3 |
Northern | 1/73 | 1.4% | 0.0-7.4 | 40/73 | 54.8% | 42.7-66.5 | 21/73 | 28.8% | 18.8-40.6 |
Gender | |||||||||
Male | 7/310 | 2.3% | 1.0-4.8 | 88/310 | 28.4% | 23.5-33.8 | 63/310 | 20.3% | 16.1-25.3 |
Female | 5/60 | 8.3% | 2.8-18.4 | 19/60 | 31.7% | 20.3-45.0 | 12/60 | 20.0% | 10.8-32.3 |
Ethnic group | |||||||||
Fijian | 9/137 | 6.6% | 3.0-12.1 | 73/137 | 53.3% | 44.6-61.9 | 50/137 | 36.5% | 28.4-45.1 |
Indian | 1/204 | 0.5% | 0.0-2.7 | 20/204 | 9.8% | 6.1-14.7 | 15/204 | 7.4% | 4.2-11.8 |
Others | 2/29 | 6.9% | 0.8-22.8 | 14/29 | 48.3% | 29.4-67.5 | 10/29 | 34.5% | 17.9-54.3 |